Kaidi Medical is a developer of tumor immunotherapy drugs.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Mar 10, 2022 | Series A | ¥100M | 2 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Kangyuan Huiying | — | Series A |
Longmen Capital | — | Series A |